Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Cancer Therapy Market Heading Into 2029?

In recent times, the size of the cancer therapy market has expanded swiftly. The market which is expected to be $190.44 billion in 2024, is projected to escalate to $210.44 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. Factors such as the increased global occurrence of cancer, the growth in the uptake of chemotherapy procedures, rising consciousness about early detection of cancer, the augmented presence of oncology experts, and the improved access to hospital-oriented treatment services have contributed to the growth during the historical period.

In the coming years, the cancer therapy market is predicted to witness significant expansion. It is projected to reach a whopping $310.85 billion in 2029, increasing at a compound annual growth rate (CAGR) of 10.2%. The surge during the forecast period is attributable to the rising demand for custom-tailored cancer treatments, an amplified focus on outpatient cancer care, increased use of immunotherapy, wider access to healthcare in developing economies, and the growing prevalence of lifestyle-related cancers. Key trends for the forecast period include technological breakthroughs in cancer detection, advancements in targeted drug delivery techniques, augmented investment in biologics’ research and development, adoption of AI in devising treatment plans, and advancements in less invasive cancer surgery procedures.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

Which Factors Are Pushing The Cancer Therapy Market Forward?

The escalating incidence of cancer is projected to stimulate the expansion of the cancer therapy market in the future. Cancer constitutes a collection of illnesses marked by unchecked growth and dissemination of unusual cells in the body. The rise in cancer is predominantly attributable to enhanced exposure to environmental carcinogens like pollution and tobacco smoke. Cancer therapy is instrumental in controlling the escalating incidence of cancer by handling current cases, enhancing survival rates, and curtailing disease progression. For example, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, in February 2024, the global cancer incidence is predicted to surpass 35 million new cases by 2050, a 77% rise from the projected 20 million cases registered in 2022. Consequently, the escalating incidence of cancer is propelling the cancer therapy market.

Which Segment Held The Largest Share In The Cancer Therapy Market In 2025?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegment:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

How Are Key Trends Driving Expansion In The Cancer Therapy Industry?

Leading companies in the cancer therapy market are prioritizing the development of innovative therapies, such as immuno-oncology drugs, to improve treatment outcomes by using the body’s immune system to identify and eliminate cancer cells. Immuno-oncology drugs, a type of cancer treatment, work by boosting or enhancing the body’s immune system to more effectively recognize and attack cancer cells. For example, in December 2024, Toripalimab, the first and only immuno-oncology medication approved for nasopharyngeal cancer treatment, was launched in India by Dr. Reddy’s Laboratories Ltd., a pharmaceutical company based in India. This introduction opens up a new, customized treatment channel for those affected by this uncommon, highly aggressive cancer, with the potential to improve results via advanced immune system activation. Dr. Reddy’s has shown its dedication to broadening access to pioneering cancer therapies in underprivileged areas with the availability of toripalimab in India.

Which Organizations Are Driving Progress In The Cancer Therapy Industry?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Cancer Therapy Industry?

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24492&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model